The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

Atrial flutter occurs when a “reentrant” circuit is present, causing a repeated loop of electrical activity to depolarize the atrium at a rate of about 250 to 350 beats per minute; the atrial ...

MAT is characterized by three different P-wave morphologies within one 10-second 12-lead ECG at a heart rate ... risk in MAT such is seen in atrial fibrillation/flutter, since the atrium are ...